KRYS — Krystal Biotech, Inc.
8 mentions in the last 24 hours · 0.07% of all mentions
Why people talked about KRYS (2026-11-02)
- Krystal Biotech reported Q3 2026 financial results with GAAP EPS of $2.05, beating estimates by $0.28.
- The company achieved revenue of $1.1 billion, surpassing expectations by $973.46 million.
| Bluesky | 4 | community |
| GDELT | 2 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |